News - UF Innovate

Yikes! Scientists Discover Factor That Directs Brain’s Fear Conditioning

A team led by neuroscientists at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology has discovered a key molecular player in fear conditioning. It’s a specialized RNA with a memorable acronym, SLAMR. Their study found SLAMR must be present in adequate quantities for neurons to build the complex connections required for fear conditioning. Their research appears in the journal Nature Communications.

Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands Product Series to Breath Logix

UF startup Cannabix Technologies Inc., developer of marijuana and alcohol breath-testing devices reports that it has shipped its Industrial Series Contactless Alcohol Breathalyzers (“CAB” devices) for certification testing and is rebranding the “CAB” name under the new “Breath Logix” product series, part of the company’s portfolio of marijuana and alcohol screening devices.

Researchers Create a New AI Pipeline for Identifying Molecular Interactions

Understanding how proteins interact with each other is crucial for developing new treatments and understanding diseases. Thanks to computational advances, a team of researchers led by Assistant Professor of Chemistry Alberto Perez have developed a groundbreaking algorithm to identify these molecular interactions.

Agriculture Intelligence to Feature in the 2024 AI in AG Conference at Texas A&M University

Agriculture Intelligence, a leader in agricultural science technology, is proud to announce its participation in the upcoming AI in AG conference, scheduled for April 15-17 at Texas A&M University. The conference will gather experts and leaders from across the industry to discuss the integration of advanced technologies in agriculture.

Fang Invited to Present at the National Academies’ Workshop on Bidirectionality Between AI & Neuroscience

UF researcher Dr. Ruogu Fang was invited to present at The National Academies’ Workshop on Bidirectionality between AI and Neuroscience. The invitation comes from The National Academies Forum on Neuroscience and Nervous System Disorders, organizing a hybrid workshop titled “Exploring the Bidirectional Relationship between Artificial Intelligence and Neuroscience.” The workshop occurred on March 25-26 in Washington, D.C.

UF-Led Researchers Link New Genetic Mutation to Increased Risk of Parkinson’s

New research by a University of Florida-led international team has revealed evidence linking a new genetic mutation to greater risk of developing Parkinson’s disease.

New 3D-Printing Method Makes Printing Objects More Affordable and Eco-Friendly

University of Florida engineers have developed a method for 3D printing called vapor-induced phase-separation 3D printing, or VIPS-3D, to create single-material and multi-material objects.

Ascend Acquires Beacon Gene Therapy Manufacturing Site

Ascend Advanced Therapies, a gene therapy development partner, has purchased Beacon Therapeutics’ contract, manufacturing, and controls team—along with the company's site, previously owned by UF Innovate | Accelerate graduate AGTC, located in Alachua, FL—a town considered to be a “biotech hub” in the state. The acquisition introduces a good manufacturing practice (GMP) plant into the fold, along with process and analytical development capabilities.

Private Investigators and Emerging Tech Are Helping To Crack Down on Beauty’s Retail Crime

California Highway Patrol’s Organized Retail Crime Taskforce has recovered more than $41 million worth of stolen goods since the program launched in 2019.

UF Team Plays Major Role in Success of Newly Approved Duchenne Muscular Dystrophy Drug

Duchenne muscular dystrophy families, advocates and healthcare providers celebrated a milestone in March with the U.S. Food and Drug Administration’s approval of the first nonsteroidal drug for the treatment of Duchenne. The University of Florida's expertise in magnetic resonance imaging provided objective, measurable results in the drug's clinical trials.

UF News